A Phase I Study of QL1604 for Advanced Solid Tumors
Clinical trial NCT05801094 · UNKNOWN
Trial details
- NCT number
- NCT05801094
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2023-04-15
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.